Not applicableNot Yet RecruitingNCT07443592What this trial is testingTreatment for Ph-negative ALL for Adults up to 65 YearsWho this might be right forAcute Lymphoblastic Leukemia PETHEMA Foundation 330
Early research (Phase 1)Study completedNCT00352677What this trial is testingSafety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic LeukemiaWho this might be right forChronic Myeloid LeukemiaAcute Lymphocytic Leukemia CytRx 100
Large-scale testing (Phase 3)Active Not RecruitingNCT02003222What this trial is testingCombination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative National Cancer Institute (NCI) 488
Testing effectiveness (Phase 2)Study completedNCT01724879What this trial is testingStudy of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)Who this might be right forPhiladelphia Positive Acute Lymphoblastic Leukemia Goethe University 19
Large-scale testing (Phase 3)Active Not RecruitingNCT04722848What this trial is testingSequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALLWho this might be right forAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)ALL, AdultPhiladelphia-Positive ALL Gruppo Italiano Malattie EMatologiche dell'Adulto 236
Not applicableStudy completedNCT00068523What this trial is testingUltraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Case Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00384228What this trial is testingA Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALLWho this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Novartis Pharmaceuticals 42
Not applicableLooking for participantsNCT06237192What this trial is testingMRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult PatientsWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma National Research Center for Hematology, Russia 200
Testing effectiveness (Phase 2)Looking for participantsNCT07227584What this trial is testingALL Backbone in AYAsWho this might be right forAcute Lymphoblastic LeukemiaPhiladelphia Chromosome-Negative Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia (ALL)+1 more Dana-Farber Cancer Institute 67
Post-approval studies (Phase 4)Study completedNCT00853008What this trial is testingTreatment of High Risk Adult Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia PETHEMA Foundation 100
Testing effectiveness (Phase 2)Study completedNCT00061945What this trial is testingAlemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaWho this might be right forAcute Undifferentiated LeukemiaB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic Leukemia+11 more National Cancer Institute (NCI) 302
Testing effectiveness (Phase 2)Study completedNCT04554485What this trial is testingBlinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)Who this might be right forLymphoblastic Leukemia, Acute, AdultPh Negative ALLNewly Diagnosed Institute of Hematology and Blood Transfusion, Czech Republic 27
Testing effectiveness (Phase 2)Looking for participantsNCT07387926What this trial is testingSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00458848What this trial is testingChemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 470
Testing effectiveness (Phase 2)Study completedNCT01004497What this trial is testingFirst-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALLWho this might be right forAcute Lymphoblastic Leukemia The Catholic University of Korea 51
Testing effectiveness (Phase 2)Study completedNCT01769209What this trial is testingBortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forB-cell Adult Acute Lymphoblastic Leukemia (ALL)Ph-positive Adult Acute Lymphoblastic Leukemia (ALL)Recurrent Adult Acute Lymphoblastic Leukemia (ALL)+1 more Stanford University 18
Not applicableLooking for participantsNCT07454226What this trial is testingABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALLWho this might be right forPh-LikeAcute Lymphoblastic Leukemia Institute of Hematology & Blood Diseases Hospital, China 92
Testing effectiveness (Phase 2)Ended earlyNCT01028716What this trial is testingDonor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more Fred Hutchinson Cancer Center 46
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Not applicableUnknownNCT03318770What this trial is testingPost-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 60